However, the ARG1 siRNA/PEI–isoprenaline complex treatment group demonstrated a significant decrease in ARG1 gene expression, with ARG1 expression suppressed by approximately 63% compared with that of the untreated asthma group. This evidence concerns the gene ARG1 and asthma.